Biostera - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 61,582 | 59,359 | 70,742 | 157,372 | 342,252 | 447,567 | 554,954 | 676,554 |
| Profit before tax | 8,005 | -2,197 | 2,195 | 16,518 | 70,912 | 69,604 | 76,255 | 98,636 |
| Net profit | 7,605 | -2,197 | 2,195 | 15,692 | 60,275 | 58,943 | 64,787 | 82,790 |
| Equity | 11,923 | 9,726 | 11,921 | 27,613 | 87,888 | 146,831 | 211,618 | 294,408 |
| Liabilities | - | - | - | - | 25,363 | 22,743 | 38,152 | 57,688 |
| Non-current assets | 0 | 0 | 4,597 | 15,207 | 27,564 | 74,732 | 100,188 | 124,131 |
| Current assets | 19,236 | 10,184 | 14,491 | 29,314 | 85,687 | 94,842 | 149,582 | 227,965 |
| Total assets | 19,236 | 10,184 | 19,088 | 44,521 | 113,251 | 169,574 | 249,770 | 352,096 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 76,792 | 104,569 | 109,149 |
| Social insurance contributions | - | - | - | - | - | 17,764 | 31,304 | 41,247 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +124.0% | -3.6% | +19.2% | +122.5% | +117.5% | +30.8% | +24.0% | +21.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 39.5% | -21.6% | 11.5% | 35.2% | 53.2% | 34.8% | 25.9% | 23.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 63.8% | -22.6% | 18.4% | 56.8% | 68.6% | 40.1% | 30.6% | 28.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.3% | -3.7% | 3.1% | 10.0% | 17.6% | 13.2% | 11.7% | 12.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 13.0% | -3.7% | 3.1% | 10.5% | 20.7% | 15.6% | 13.7% | 14.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.3 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 157,372 | 128,343 | 99,459 | 75,676 | 88,246 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biostera - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-04 | 2025-05-04 | 7.70 |
Biostera - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-01 | 2025-05-01 | 13.49 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biostera, MB (company code 304502761) is a Small partnership operating in plumbing, heat and air-conditioning installation. In 2025, the company generated revenue of EUR 676.6K, up 21.9% year on year and 51.2% over two years, showing steady growth across 2023–2025. Net profit increased from EUR 58.9K in 2023 to EUR 64.8K in 2024 and EUR 82.8K in 2025, while the profit margin remained broadly stable at 13.2% in 2023, 11.7% in 2024 and 12.2% in 2025. Profit before tax also rose to EUR 98.6K in 2025. The balance sheet expanded from EUR 169.6K in 2023 to EUR 352.1K in 2025, supported by equity growth to EUR 294.4K and liabilities of EUR 57.7K. The equity ratio stood at 83.6%, with debt-to-equity at 0.20. Return on equity was 28.1% and return on assets 23.5% in 2025. Asset turnover reached 1.92x. Revenue per employee was EUR 96.7K and profit per employee EUR 11.8K, indicating solid operating productivity.